4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-20-063359
Options or other derivatives
- Chief Financial Officer acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Estepan Ian Michael · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-12-14 | Grant or award : show line 1 in the form Stock option (right to buy) | +25,000 | $169.54 | 2030-12-14 | 25,000 | 25,000 | D |
Loading xslF345X03/doc4.xml…